Formulation studies of benzydamine mucoadhesive formulations for vaginal administration

Drug Development and Industrial Pharmacy

Volumn 35, Issue 7, 2009, Pages 769-779

  Perioli, Luana ^a   Ambrogi, Valeria ^a   Venezia, Lorena ^a   Giovagnoli, Stefano ^a   Pagano, Cinzia ^a   Rossi, Carlo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Benzydamine; Emulgels; Mucoadhesion; Rheology; Vaginal inflammation

Indexed keywords

BENZOIC ACID; BENZYDAMINE; CARBOXYMETHYLCELLULOSE; CETOMACROGOL; CETOSTEARYLIC ALCOHOL; CITRATE SODIUM; CITRIC ACID; GLYCEROL; HYDROXYETHYLCELLULOSE; OIL; PROPYLENE GLYCOL; TRIACYLGLYCEROL; WATER; WHITE PETROLATUM;

ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREAM; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; EX VIVO STUDY; FEMALE; FLOW KINETICS; GEL; MARKET; MUCOADHESION; NONHUMAN; SOLID; STRENGTH; VAGINA MUCOSA; VISCOSITY;

ADHESIVENESS; ADMINISTRATION, INTRAVAGINAL; ANIMALS; BENZYDAMINE; CHEMISTRY, PHARMACEUTICAL; FEMALE; MUCOUS MEMBRANE; SWINE; VAGINA; VAGINAL CREAMS, FOAMS, AND JELLIES; VISCOSITY;

EID: 70350656067     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040802592435     Document Type: Article

References (22)

1. Sobel JD. (1997). Vaginitis. N Engl J Med, 337:1896-1903
2. Johnston VJ, Mabey DC. (2008). Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis, 21(1):56-64.
3. Kukner S, Ergin T, Cicek N, Ugur M, Yesilyurt H, Gokmen O. (1996). Treatment of vaginitis. Int J Gynaecol Obstet, 52:43-47
4. Magliano EM, Conti M, Clerici P, Laurita L. (1987). The role of benzydamine in the topical treatment of the so-called nonspecific vaginitis. Int J Tissue React, 9(2):151-156
5. Silvestrini B. (1986). Patent use of benzydamine in the treatment of the Trichomonas vaginalis and Gardnerella vaginalis infections, EP0195749.
6. Ceschel GC, Maffei P, Borgia SL, Ronchi C, Rossi S. (2001). Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm, 27:541-547
7. Vermani K, Garg S. (2000). The scope and potential of vaginal drug delivery. Pharm Sci Technol Today, 3:359-364
8. Knut K, Amiji M, Robinson JR. (1993). Hydrogel delivery systems for vaginal and oral applications - Formulation and biological considerations. Adv Drug Deliv Rev, 11:137-167
9. Lee JW, Park JH, Robinson JR. (2000). Bioadhesive-based dosage forms: The next generation. J Pharm Sci, 89:850-866
10. Bonferoni MC, Giunchedi P, Scalia S, Rossi S, Sandri G, Caramella C. (2006). Chitosan gels for the vaginal delivery of lactic acid: Relevance of formulation parameters to mucoadhesion and release mechanisms. AAAPSPharmSciTech, article 104. http://www.aapspharmscitech.org
11. Jones DS, Woolfson AD, Brown AF. (1997). Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. Int J Pharm, 151:223-233
12. Parson D, Harwood RJ. (2000). Carboxymethylcellulose sodium and hydroxyethylcellulose. In: Kibbe H, ed. Handbook of pharmaceutical excipients, 3rd ed. Washington, D.C.: American Pharmaceutical Association, 87-90 and 240-243
13. Perioli L, Ambrogi V, Angelici F, Ricci M, Giovagnoli S, Capuccella M, et al. (2004). Development of mucoadhesive patches for buccal administration of ibuprofen. J Control Release, 99:73-82.
14. Das Neves J, Bahia MF. (2006). Gels as vaginal drug delivery systems. Int J Pharm, 318:1-14.
15. Pavelic Ž, Škalko-Basnet N, Jalšenjak I. (2005). Characterisation and in vitro evaluation of bioadhesive liposome gels for local therapy of vaginitis. Int J Pharm, 301:140-148
16. Perioli L, Ambrogi V, Giovagnoli S, Ricci M, Blasi P, Rossi C. (2007). Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen. AAAPSPharmSciTech, article 54. http:// www.aapspharmscitech.org
17. Refai H, Müller-Goymann CC. (2002). The influence of dilution of topical semisolid preparations on hydrocortisone permeation through excised human stratum corneum. Eur J Pharm Biopharm, 54:143-150
18. Prudat-Christiansen C, Arnaud P, Allain P, Chaumeil JC. (1996). Aminophilline bioadhesive tablets attempted by wet granulation. Int J Pharm, 141:109-116
19. Bertram U, Bodmeier R. (2006). In situ gelling, bioadhesive nasal inserts for extended drug delivery: In vitro characterization of a new nasal dosage form. Eur J Pharm Sci, 27:62-71.
20. Madsen F, Eberth K, Smarth JD. (1998). A rheological examination of the mucoadhesive/mucus interaction: The effect of mucoadhesive type and concentration. J Control Release, 50(1-3):167-178
21. El-Kamel AH, Sokar MS, Naggar VF, Al Gamal SS. (2002). Bioadhesive controlled release metronidazole vaginal tablets. Acta Pharm, 52:171-179
22. Ritger P, Peppas NA. (1987). A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release, 5:37-42.